Unlock the future of regenerative medicine and oncology with Evotec’s integrated cell therapy platform. By combining the scalability of iPSCs with proprietary immune-shielding and in-house GMP manufacturing, we are transforming complex science into affordable, "off-the-shelf" curative treatments.
Download the factsheet to see how our end-to-end capabilities from gene editing to specialized cell production are making next-generation therapies safer and more accessible than ever before.
